Targeted gene modification in mouse ES cells using integrase-defective lentiviral vectors

Area of Science:

• Molecular Biology
• Gene Therapy
• Stem Cell Research

Background:

• Lentiviral vectors are widely used for stable transgene expression due to efficient genome integration.
• However, random integration poses risks of insertional mutagenesis and oncogenesis.
• Developing safer gene delivery methods is crucial for therapeutic applications.

Purpose of the Study:

• To investigate the feasibility of lentiviral vector-mediated gene targeting in murine embryonic stem (ES) cells.
• To assess the efficacy of integrase-defective lentiviral (IDLV) vectors in reducing random integration.
• To confirm the pluripotency and germline transmission of gene-targeted ES cells.

Main Methods:

• Utilized integrase-defective lentiviral (IDLV) vectors for gene targeting in murine ES cells.
• Compared homologous recombination efficiency with wild-type lentiviral vectors.
• Selected G418 resistant clones and confirmed homologous recombination.
• Generated chimeric mice from targeted ES cells to assess pluripotency and germline transmission.

Main Results:

• Wild-type lentiviral vectors did not yield any homologous recombinant clones.
• IDLV vectors achieved successful homologous recombination in 0.83% of G418 resistant clones.
• Targeted ES cells maintained pluripotency, confirmed by germline transmission in chimeric mice.

Conclusions:

• IDLV vectors significantly decrease random integration, enabling targeted gene manipulation in ES cells.
• This strategy offers a safer approach for gene modification in stem cells.
• The findings have potential implications for secure gene therapy applications.